Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of CAR T cell therapy for the treatment of cancer and autoimmune diseases; gene editing, namely, pharmaceutical research and development in the field of CAR T cell therapy for the treatment of cancer and autoimmune diseases

'autoimmun':30,53 'cancer':28,51 'car':20,43 'cell':22,45 'develop':38 'diseas':13,31,54 'disord':15 'edit':2,33 'field':18,41 'gene':1,32 'genet':12 'medic':4 'name':3,34 'pharmaceut':35 'research':7,36 'scientif':6 'therapi':23,46 'treatment':10,26,49

Cells for medical or clinical use in the field of CAR T cell therapy for the treatment of cancer and autoimmune diseases; pharmaceutical and biopharmaceutical agents for the treatment of cancer in the field of CAR T cell therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer in the field of CAR T cell therapy

'agent':26 'autoimmun':21 'biopharmaceut':25 'cancer':19,31,55 'car':11,36,60 'cell':1,13,38,62 'clinic':5 'deliveri':49 'diseas':22 'field':9,34,58 'gene':40,44 'medic':3 'modul':47 'name':43 'pharmaceut':23,50 'product':42 'regul':46 'therapi':14,39,41,63 'transfer':45 'treatment':17,29,53 'use':6

CTX112

Owners

Goods & Services